AMN
Clinical trials for AMN explained in plain language.
Never miss a new study
Get alerted when new AMN trials appear
Sign up with your email to follow new studies for AMN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Spinal injection gene therapy tested for rare nerve disease
Disease control TerminatedThis study tested a one-time gene therapy injection into the spinal fluid for adults with a rare, progressive nerve disease called adrenomyeloneuropathy (AMN). The goal was to see if delivering a working copy of a faulty gene could be safe and potentially slow down the worsening …
Matched conditions: AMN
Phase: PHASE1, PHASE2 • Sponsor: SwanBio Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scientists track rare nerve disease to pave way for future treatments
Knowledge-focused TerminatedThis study aimed to better understand how disabilities from Adrenomyeloneuropathy (AMN) change over time in adults. Researchers observed 65 adult men with AMN to track their walking ability and quality of life. The goal was to gather information to help design future treatment tr…
Matched conditions: AMN
Sponsor: SwanBio Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Mar 18, 2026 18:25 UTC